Fundz Deep Dive
Everything you need to win Disc — in one platform.
Who to reach, what to say, and why now on Disc — plus every funding round, exec hire, and M&A move that follows, each with the verified contact and the outreach written for you.
Get the full Deep Dive on Disc — free.
One free Deep Dive, emailed to you. No spam; unsubscribe anytime.
Ready now? Choose your plan · Request a demo · Sign in
Engage writes the reply
Grounded in signals no one else has — tuned to their persona.
Signals no one else has
UCC liens, benefit plans, 13F holdings, permits, exec moves — fused.
Verified contact + click-to-call
The decision-maker’s email and mobile — dial in-browser.
Disc Medicine Secures $200 Million Non-Dilutive Debt Financing from Hercules Capital, Inc.
Nov 08, 2024•over 1 year ago
Contract Type
partnership
WatertownBiotechnologyHealth CareTherapeuticsPharmaceuticalBiopharmaDescription
Disc Medicine, Inc. has announced the securing of a $200 million non-dilutive term loan facility from Hercules Capital, Inc. to support anticipated key catalysts, including the expected initiation of a confirmatory study of bitopertin in erythropoietic protoporphyria (EPP) and other important studies.
Related People
Suggested for you
Agreement Insights
Based on industry dataStrategic partnership established
Partnership agreements typically involve technology integration and joint go-to-market strategies
Contract momentum indicator
Companies with recent agreements are 2.3x more likely to make additional purchases within 6 months